版本:
中国

BRIEF-Quidel receives PMDA approval for its point-of-care SOFIA Influenza A+B Assay

May 24 Quidel Corp

* Quidel receives PMDA approval for its point-of-care Sofia Influenza A+B Assay

* Approval from Japan's PMDA for Sofia Influenza A+B fluorescent immunoassay to be used with Sofia Fluorescent Immunoassay Analyzer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐